CancerFree is a biotech company dedicated to cancer diagnosis and treatment from blood samples. It is the first company to commercialize an in-vitro tumor cell culture platform from liquid biopsies. The company's proprietary technology operates by using circulating tumor cell culture from a patient to form organoid systems. These systems can help doctors and patients identify the optimal treatment strategy to fight cancer, particularly late stage cancer.

CanceFree has both patents and registered IP for its proprietary technology in Taiwan and the United States.